Holders — by stockHoldings — by fund
Artia Global Partners LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001937964
$541.9M
disclosed book value
48
positions
12.7%
largest position share
Positions, as of 2026-06-30
top 48 of 48 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 516,447 | $68.8M | 12.7% |
| 2 | INSMINSMED INC | 589,052 | $62.8M | 11.6% |
| 3 | TRVITREVI THERAPEUTICS INC | 2.2M | $41.2M | 7.6% |
| 4 | BTSGBRIGHTSPRING HEALTH SVCS INC | 517,315 | $36.1M | 6.7% |
| 5 | RVMDREVOLUTION MEDICINES INC | 185,390 | $34.7M | 6.4% |
| 6 | ARGXARGENX SE | 29,739 | $27.6M | 5.1% |
| 7 | ALKERMES PLC | 448,964 | $23.5M | 4.3% |
| 8 | TVTXTRAVERE THERAPEUTICS INC | 339,033 | $19.3M | 3.6% |
| 9 | ASTRAZENECA PLC | 98,376 | $18.7M | 3.4% |
| 10 | NEWAMSTERDAM PHARMA COMPANY | 503,936 | $17.1M | 3.2% |
| 11 | DNTHDIANTHUS THERAPEUTICS INC | 162,990 | $15.9M | 2.9% |
| 12 | XBISPDR SERIES TRUSTPUT | 100,000 | $15.8M | 2.9% |
| 13 | DGXQUEST DIAGNOSTICS INC | 65,122 | $13.8M | 2.5% |
| 14 | IONSIONIS PHARMACEUTICALS INC | 144,376 | $11.4M | 2.1% |
| 15 | EYPTEYEPOINT INC | 767,098 | $11.0M | 2% |
| 16 | ALMSALUMIS INC | 278,546 | $7.8M | 1.4% |
| 17 | VKTXVIKING THERAPEUTICS INC | 180,731 | $7.1M | 1.3% |
| 18 | CELCCELCUITY INC | 59,316 | $6.2M | 1.1% |
| 19 | CYTKCYTOKINETICS INC | 70,700 | $6.0M | 1.1% |
| 20 | MRKMERCK & CO INC | 46,700 | $6.0M | 1.1% |
| 21 | RAPPRAPPORT THERAPEUTICS INC | 138,508 | $5.8M | 1.1% |
| 22 | JNJJOHNSON & JOHNSON | 22,600 | $5.7M | 1.1% |
| 23 | GHGUARDANT HEALTH INC | 38,100 | $5.7M | 1.1% |
| 24 | ABSIABSCI CORPORATION | 464,444 | $5.4M | 1% |
| 25 | SRRKSCHOLAR ROCK HLDG CORP | 96,285 | $5.3M | 1% |
| 26 | SIONSIONNA THERAPEUTICS INC | 119,741 | $5.3M | 1% |
| 27 | ASCENDIS PHARMA A/S | 17,740 | $4.7M | 0.9% |
| 28 | ROIVANT SCIENCES LTD | 129,800 | $4.6M | 0.8% |
| 29 | PALIPALISADE BIO INC | 2.0M | $4.2M | 0.8% |
| 30 | EWTXEDGEWISE THERAPEUTICS INC | 98,800 | $4.0M | 0.7% |
| 31 | BIIBBIOGEN INC | 18,437 | $4.0M | 0.7% |
| 32 | XENEXENON PHARMACEUTICALS INC | 65,000 | $3.9M | 0.7% |
| 33 | BLTEBELITE BIO INC | 24,989 | $3.8M | 0.7% |
| 34 | MLYSMINERALYS THERAPEUTICS INC | 137,800 | $3.7M | 0.7% |
| 35 | PROKPROKIDNEY CORP | 1.8M | $3.7M | 0.7% |
| 36 | ELVNENLIVEN THERAPEUTICS INC | 72,100 | $3.7M | 0.7% |
| 37 | ORKAORUKA THERAPEUTICS INC | 33,400 | $3.2M | 0.6% |
| 38 | PTGXPROTAGONIST THERAPEUTICS INC | 22,951 | $2.8M | 0.5% |
| 39 | UTHRUNITED THERAPEUTICS CORP DEL | 5,000 | $2.7M | 0.5% |
| 40 | DRUGBRIGHT MINDS BIOSCIENCES INC | 38,407 | $2.7M | 0.5% |
| 41 | KINIKSA PHARMACEUTICALS INTL | 29,200 | $1.9M | 0.3% |
| 42 | CMPXCOMPASS THERAPEUTICS INC | 383,200 | $839,208 | 0.2% |
| 43 | PRAXPRAXIS PRECISION MEDICINES I | 2,500 | $836,975 | 0.2% |
| 44 | KODKODIAK SCIENCES INC | 17,019 | $663,060 | 0.1% |
| 45 | TENXTENAX THERAPEUTICS INC | 42,080 | $612,264 | 0.1% |
| 46 | NUVALENT INC | 4,900 | $605,150 | 0.1% |
| 47 | PEPGPEPGEN INC | 205,324 | $369,583 | 0.1% |
| 48 | SYRESPYRE THERAPEUTICS INC | 4,000 | $355,120 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.